Finance

Lists
UNICHEMLAB:NSE
Unichem Laboratories Ltd
₹554.00
-2.76%
(-15.75) 1D
Sep 8, 3:30:01 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for UNICHEMLAB...
Open
₹567.00
High
₹575.20
Low
₹552.40
Mkt. cap
39.00B
Avg. vol.
0.00
Volume
72.97K
P/E ratio
12.82
52-wk high
₹687.20
52-wk low
₹278.20
EPS
₹43.22
Shares outstanding
70.38M
No. of employees
3K
Open
₹567.00
High
₹575.20
Low
₹552.40
Mkt. cap
39.00B
Avg. vol.
0.00
Volume
72.97K
P/E ratio
12.82
52-wk high
₹687.20
52-wk low
₹278.20
EPS
₹43.22
Shares outstanding
70.38M
No. of employees
3K
Profile
Unichem Laboratories is an Indian pharmaceutical company, headquartered in Mumbai. It manufactures and markets pharmaceutical formulations across the globe, including the regulated markets of the USA and Europe. Wikipedia
About Unichem Laboratories Ltd
CEO-
Employees2.78K
Founded1944
HeadquartersMumbai, Maharashtra, India
SectorPharmaceutical industry
Websiteunichemlabs.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.79B
5.21B
5.75B
6.33B
Cost of goods sold
2.70B
2.37B
3.41B
2.89B
Cost of revenue
2.70B
2.37B
3.41B
2.89B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.00B
992.70M
1.05B
1.03B
Operating expense
2.74B
2.71B
2.10B
3.04B
Total operating expenses
5.44B
5.08B
5.50B
5.93B
Operating income
347.10M
135.30M
246.30M
400.00M
Other non operating income
209.70M
118.00M
-389.10M
156.10M
EBT including unusual items
-108.20M
2.93B
187.90M
489.90M
EBT excluding unusual items
474.40M
179.10M
271.70M
489.90M
Income tax expense
10.70M
291.40M
78.80M
75.20M
Effective tax rate
-9.89%
9.93%
41.94%
15.35%
Other operating expenses
1.42B
1.40B
743.50M
1.71B
Net income
-118.90M
2.64B
109.10M
414.70M
Net profit margin
-2.05%
50.71%
1.90%
6.56%
Earnings per share
-
-
-
-
Interest and investment income
-
-
53.00M
-
Interest expense
-82.40M
-74.20M
-92.80M
-66.20M
Net interest expenses
-82.40M
-74.20M
-39.80M
-66.20M
Depreciation and amortization charges
314.70M
312.50M
306.10M
299.40M
EBITDA
663.40M
428.72M
541.10M
694.80M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps